The Taipei Medical University Shuang-Ho Hospital is a hospital in Zhonghe District, New Taipei, Taiwan. It is the affiliated hospital of Taipei Medical University.

There are 1,500 beds in Taipei Medical University Shuang Ho Hospital.

During the past decade, Taipei Medical University Shuang Ho Hospital conducted 129 clinical trials. In the 10-year time frame, 129 clinical trials started and 30 clinical trials were completed, i.e. on average, 23.3% percent of trials that started reached the finish line to date. In the past 5 years, 81 clinical trials started and 25 clinical trials were completed. i.e. 30.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Taipei Medical University Shuang Ho Hospital" #1 sponsor was "Taipei Medical University Shuang Ho Hospital" with 33 trials, followed by "Eli Lilly and Company" with 12 trials sponsored, "Taipei Medical University" with 11 trials sponsored, "Janssen Research & Development, LLC" with 9 trials sponsored and "Pfizer" with 9 trials sponsored. Other sponsors include 66 different institutions and companies that sponsored additional 53 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Taipei Medical University Shuang Ho Hospital" #1 collaborator was "Taipei Medical University Shuang Ho Hospital" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Incyte Corporation" with 3 trials as a collaborator, "PharmaEssentia" with 3 trials as a collaborator and "Chang Gung Memorial Hospital" with 2 trials as a collaborator. Other collaborators include 46 different institutions and companies that were collaborators in the rest 51 trials.

According to Clinical.Site data, the most researched conditions in "Taipei Medical University Shuang Ho Hospital" are "Stroke" (7 trials), "Atopic Dermatitis" (6 trials), "Breast Cancer" (6 trials), "Psoriasis" (4 trials) and "Type 2 Diabetes Mellitus" (4 trials). Many other conditions were trialed in "Taipei Medical University Shuang Ho Hospital" in a lesser frequency.

Most popular intervention types in "Taipei Medical University Shuang Ho Hospital" are "Drug" (85 trials), "Other" (24 trials), "Device" (17 trials), "Behavioral" (13 trials) and "Biological" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Carboplatin" (4 trials), "Pemetrexed" (4 trials), "Amivantamab" (3 trials) and "Astragalus Polysaccharides 500 mg" (3 trials). Other intervention names were less common.

The vast majority of trials in "Taipei Medical University Shuang Ho Hospital" are 137 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Taipei Medical University Shuang Ho Hospital". 5 are not yet recruiting, 41 are recruiting, 25 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Taipei Medical University Shuang Ho Hospital, 1 suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in Taipei Medical University Shuang Ho Hospital, 18 "Phase 1" clinical trials were conducted, 25 "Phase 2" clinical trials and 47 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 43 trials that are defined as “Not Applicable".